The challenge of modulating β-cell autoimmunity in type 1 diabetes
Mark A. Atkinson(University of Florida), Mark Peakman(Sanofi (France)), Amanda L. Posgai(University of Florida), Daniel Wheeler(King's College London), Bart O. Roep(Immune Regulation (United Kingdom))
Cited by 165
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k